Table 3.

Performance tracking options during initiatives to reduce reoperation and improve cosmetic outcome

1. Core needle biopsy rate for cancer diagnosis*

2. Specimen imaging rate*

3. Specimen orientation rate*

4. Rate of ink positive margins at initial lumpectomy

5. Compliance rate with SSO-ASTRO margin statement

6. Reoperation rate after initial lumpectomy for breast cancer*

7. Breast conserving therapy rate

8. Cost/charges per episode of care

9. Patient reported outcomes to include cosmetic outcome after lumpectomy*

10. Ipsilateral breast tumor recurrence rate

* ASBrS endorsed Quality Measure audited in Mastery Program37